Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea · Delayed Price · Currency is KRW 73,700
+2,000 (2.79%)
Last updated: Jun 16, 2026, 2:03 PM KST
KRX:185750 Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, KRX:185750 stock has a consensus rating of "Buy" and an average price target of ₩119,167. The average 1-year stock price forecast is 61.69% higher than the current stock price, while the lowest is ₩100,000 (+35.69%) and the highest is ₩155,000 (+110.31%).
Price Target: ₩119,167 (+61.69%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KRX:185750 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 6 |
Financial Forecast
Revenue This Year
1.90T
from 1.69T
Increased by 12.27%
Revenue Next Year
1.94T
from 1.90T
Increased by 2.05%
EPS This Year
4.78K
from 6.54K
Decreased by -27.00%
EPS Next Year
5.46K
from 4.78K
Increased by 14.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.9T | ||
| Avg | 1.9T | ||
| Low | 1.9T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.3% | ||
| Avg | 12.3% | ||
| Low | 12.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4,777.00 | ||
| Avg | 4,777.00 | ||
| Low | 4,777.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -27.0% | ||
| Avg | -27.0% | ||
| Low | -27.0% |